CClinicalTrials.gg
CompletedNCT03515408Updated Aug 7, 2019

Individualized Precise Localization of rTMS on Precentral and Parietal Gyrus

An interventional study of rTMS in Attention Deficit Hyperactivity Disorder, sponsored by Hangzhou Normal University. Completed at 1 site in China. Open to participants aged 19 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-08-07.

Sponsored by Hangzhou Normal University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
32
Allocation
Randomized
Ages
19 Years to 30 Years
Sex
All
01

Study summary

Attention deficit hyperactivity disorder (ADHD) patients have some problem with sustained attention. The dorsal anterior cingulate cortex (dACC) plays a key role for attention control. It has been found that the dACC has strong functional connectivity with ipsilateral motor area and parietal gyrus. Repetitive Transcranial Magnetic Stimulation (rTMS) is a sage and painless technique to activate cortical areas. The deep brain structure can be activated via stimulating superficial cortex by rTMS. For investigating the mechanism of sustained attention, this project is using functional magnetic resonance imaging (fMRI) to individualize the precise localization in motor area and parietal gyrus, and combining rTMS to activate the dACC.

Read the detailed description

Healthy subject is recruiting in this project. High rTMS will be performed. The 10-Hz stimulation is delivered at 100% of the subject's resting motor threshold via 60 trains of 3-s 10-Hz rTMS (30 pulses with 27-s duration per train).

02

Conditions studied

  • Attention Deficit Hyperactivity Disorder

Keywords

  • fMRI
  • rTMS
  • functional connectivity
03

In context

Attention Deficit Disorder with Hyperactivity

1,514 studies on the registry are indexed under Attention Deficit Disorder with Hyperactivity; 255 are open to participants now.

This study's enrollment of 32 is below the median of 72 across 1,207 interventional studies indexed under Attention Deficit Disorder with Hyperactivity.

Browse Attention Deficit Disorder with Hyperactivity studies →

Lead sponsor

Hangzhou Normal University is the lead sponsor of 21 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
19 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • There are activation in dACC, motor area and parietal gyrus during the task fMRI
  • The head motion less than 2 mm in translation or 2 degrees in rotation in any direction during the resting-state fMRI

Exclusion criteria

Exclusion Criteria:

  • Without any neuropsychiatric conditions
  • No head injury or history of epilepsy
  • Not on any medications
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
32 participants (actual)

Study arms

  • Experimental
    Real rTMS (motor area)

    Real rTMS targeting motor area for 30 min

    Device: rTMS

  • Experimental
    Real rTMS (parietal gyrus)

    Real rTMS targeting parietal gyrus for 30 min

    Device: rTMS

  • Experimental
    Real rTMS (both brain area)

    Real rTMS targeting motor area and parietal gyrus for 15 min, separately

    Device: rTMS

  • Sham comparator
    Sham rTMS

    Sham rTMS targeting motor area and parietal gyrus for 15 min, separately

    Device: rTMS

Interventions

  • DevicerTMS

    The 10-Hz stimulation is delivered at 100% of the subject's resting motor threshold via 60 trains of 3-s 10-Hz rTMS (30 pulses with 27-s duration per train).

06

What researchers measure

Primary outcomes

  1. degree of enhanced neuro-activity associated with target-specific treatment

    amplitude of low frequency fluctuation

    Time frame: through study completion, an average of 1 year

07

Study locations

1 site
  • Hangzhou Normal University,Center for Cognition and Brain Disorder
    Hangzhou, Zhejiang 310010, China
08

References and documents

Publications

  • Eldaief MC, Halko MA, Buckner RL, Pascual-Leone A. Transcranial magnetic stimulation modulates the brain's intrinsic activity in a frequency-dependent manner. Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21229-34. doi: 10.1073/pnas.1113103109. Epub 2011 Dec 12. PubMed 22160708 ↗
  • Wang JX, Rogers LM, Gross EZ, Ryals AJ, Dokucu ME, Brandstatt KL, Hermiller MS, Voss JL. Targeted enhancement of cortical-hippocampal brain networks and associative memory. Science. 2014 Aug 29;345(6200):1054-7. doi: 10.1126/science.1252900. PubMed 25170153 ↗
  • Wang J, Yang N, Liao W, Zhang H, Yan CG, Zang YF, Zuo XN. Dorsal anterior cingulate cortex in typically developing children: Laterality analysis. Dev Cogn Neurosci. 2015 Oct;15:117-29. doi: 10.1016/j.dcn.2015.10.002. PubMed 26602957 ↗

Individual participant data

Plan to share: No — The IPD data cannot be shared with other researchers right now. We will shared it two years later.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03515408
Lead sponsor
Hangzhou Normal University
Responsible party
Yu-Feng ZANG (Professor, Hangzhou Normal University) — Principal investigator
First posted
May 3, 2018
Start date
Apr 8, 2018
Primary completion
Nov 1, 2018
Completion
Nov 1, 2018
Last update
Aug 7, 2019

Study contacts

Yu-Feng Zang, M.D.
principal investigator · Hangzhou Normal University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion